NasdaqGM:CRMDPharmaceuticals
Is CorMedix (CRMD) Now Offering Value After Sharp Share Price Declines?
If you are wondering whether CorMedix at around US$6.37 is a bargain or a value trap, the next sections are going to focus squarely on what the numbers suggest about its current price.
The stock has seen sharp swings, with a 4.8% decline over the last week, a 13.2% decline over the last month, a 47.6% decline year to date, a 41.9% decline over the past year, but a 97.8% gain over three years that still leaves five year returns at a 26.8% decline.
These moves have put valuation firmly in...